RE:RE:RE:Question: Once LABS has 4 or 5 approved drugs, can they Solid1 wrote: That's more or less how I imagine it too
That Medipharm Labs gets the rights/licenses to produce these new drugs and pays a license fee.
LABS is a long way from any 'new drug'. Closest they are is with Epidiolex and even that is looking ever more unlikely in the short term given the recent ruling in the US against one (or more) of the defendants in the patent case. Drob could be a secret weapon here if the shortages are as bad as people claim and LABS can fill that void with cheaper better product. Hoping that's the case.